BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Cancer Treatment Centers Of America to Make Poster and Oral Presentations at the Society for Integrative Oncology's 10th International Conference


10/15/2013 6:20:00 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

SCHAUMBURG, Ill., Oct. 14, 2013 /PRNewswire-USNewswire/ -- The following is being released by Cancer Treatment Centers of America:

(Logo: http://photos.prnewswire.com/prnh/20090612/CTCALOGO)

Who: Cancer Treatment Centers of America (CTCA) clinical experts in the fields of oncology and integrative medicine selected to make oral and poster presentations on therapies and practices used in evidence-based integrative oncology treatments as part of the "whole person" approach to cancer care.

Where:The 10th International Conference of the Society for Integrative Oncology
Translational Science in Integrative Oncology: From Bedside, to Bench to Best Practices
Vancouver, British Columbia

When:October 20 22, 2013

What: The following is a list of the specific poster and oral presentations being made by CTCA clinical experts:*

  • Assuring Dietary Supplement Quality for Cancer Patients: An Integrated Formulary Systems Approach. Paul Reilly, ND, FABNO, NA:, Carolyn Lammersfeld, MS, RD, CSO, LD, CNSC; Tim Birdsall, ND, FABNO; Maurie Markman, MD; Joesph Coyne; Michael Levin (October 21, 11:30 p.m. PDT)
  • Is Pretreatment Serum 25-Hydroxy Vitamin D A Prognostic Indicator in Advanced Colorectal Cancer?Carolyn Lammersfeld, MS, RD, CSO, LD, CNSC; Pankaj Vashi, MD:Kristen Trukova,MS, RD, LDN, CNSC, CSO; Digant Gupta; Gwen Lambert(October 21,11:30 p.m. PDT)
  • Resveratrol Enhances Mitomycin C-Mediated Suppression of Cell Proliferation in Colon Cancer Cell Lines By Modulating Expression of Cell Cycle Regulating Genes.Irshad Ali; Don Braun, Ph.D. (October 21, 12:15 p.m. PDT)
  • Low Level Energy Laser and Chemotherapy Induced Peripheral Neuropathy.Katherine Anderson, ND, FABNO; Aisha Chilcoat, MJ, ND; Rachel Long(October 20, 7:45 p.m. PDT)
  • Group Based Community Acupuncture: Utilization and Outcomes in an Integrative Oncology Hospital Model of Care.Katherine Anderson, ND, FABNO; Brandy Valentine, MAcOM; Teri Applegate, MAcOM, LAc(October 20, 7:45 p.m. PDT)
  • Integrative Medicine: Approaches to Managing Cancer Related Fatigue.Katherine Anderson, ND, FABNO (October 20, 7:45 p.m. PDT)
  • Case Series of an Integrated Approach for Management of Intractable Chemotherapy Induced Nausea and Vomiting. Laura Sunn, MD (October 20, 7:45 p.m. PDT)
  • Clinical Implications of Delay in Diagnosis and Treatment of Breast Cancer.Christina Shannon, ND, FABNO;Dennis Citrin, MD, Ph.D.; Sara Mortensen BA; Shelly Smekens ND, FABN; James Grutsch, Ph.D. (October 20, 7:45 p.m. PDT)
  • Expression of Cell Cycle Regulating Genes in Human Peritoneal Carcinomatosis Cells Stimulated with TNF- and/or Resveratrol.Irshad Ali; Don Braun, Ph.D. (October 20, 7:45 p.m. PDT)
  • IV Micronutrient Infusions Can Positively Impact Outcomes for Patient with Malignancies Undergoing Cancer Treatment.Heather Wright, ND, FABNO; Eiko Klimant, MD, FACP; Christina Calhoun; Marie Winters, ND; Hadassah Hilewitz, ND (October 20, 7:45 p.m.PDT)
  • Integrative Management of Chemotherapy-Induced Neuropathy in Cancer Patients Using Evidence-Based Therapies.Heather Wright, ND, FABNO; Eiko Klimant, MD, FACP; Christina Calhoun,Marie Winters, ND; Hadassah Hilewitz, ND (October 20, 7:45 p.m. PDT)
  • Chemotherapy Induced Peripheral Neuropathy: An Integrative Approach - Aisha Chilcoat, ND; Edra Spevack, ND; Sara Gomendi, ND

Special

Note: CTCA presentation abstracts and interviews with presenters and lead authors are available before and after the event to discuss their presentations and findings. To schedule an interview, or learn more about any of the studies listed, please contact Susan Morris, Manager, Public Affairs at susan.morris@ctca-hope.com or 847/342-6856.

About

CTCA: Cancer Treatment Centers of America, Inc. (CTCA) is a national network of hospitals focusing on complex and advanced stage cancer. CTCA offers a comprehensive, fully integrated approach to cancer treatment and serves patients from all 50 states at facilities located in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa. Known for delivering the Mother Standard® of care and Patient Empowerment Medicine®, CTCA provides patients with information about cancer and their treatment options so they can control their treatment decisions. For more information about CTCA, go to www.cancercenter.com.

*Note all presentations are embargoed from release until the day and time (PDT) of presentation. Lead authors, spokespersons for each study appear in bold face.

SOURCE Cancer Treatment Centers of America



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES